Special Topic

Topic: Plant-Derived Vesicles: From Fundamental Biology to Precision Therapeutics

A Special Topic of Extracellular Vesicles and Circulating Nucleic Acids

ISSN 2767-6641 (Online)

Submission deadline: 20 May 2026

Guest Editors

Prof. Xiaozhou Mou
Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China.
Prof. Donghua Yang
New York College of Traditional Chinese, New York, NY, USA.
Dr. Zhangfeng Zhong
Macao Centre for Research and Develoment in Chinese Medicine, University of Macau, Macao, China.

Special Topic Introduction

Plant-derived vesicles (PDVs) have emerged as a unique class of bioactive nanoscale carriers that bridge fundamental plant biology with emerging precision therapeutics. Composed of lipids, proteins, metabolites, and nucleic acids, PDVs mediate intercellular communication within plants and exhibit notable stability, biocompatibility, and low immunogenicity when interacting across species. PDVs’ natural ability to encapsulate, protect, and deliver functional cargos positions them as a promising platform for targeted drug delivery and novel therapeutic interventions.

 

Growing evidence shows that PDVs can modulate immune responses, reshape microbiome dynamics, regulate metabolic and signaling pathways, and promote tissue repair in mammalian cells and animal models. Importantly, PDVs have demonstrated therapeutic potential across diverse medical areas, including inflammatory diseases, oncology, metabolic disorders, and regenerative medicine. These cross-species biological activities, coupled with selective tissue tropism and intrinsic therapeutic properties, underscore the expanding translational potential of PDVs. Nonetheless, several critical challenges persist, including defining vesicle biogenesis, elucidating cargo-sorting mechanisms, clarifying cellular uptake pathways, and identifying the determinants of inter-kingdom specificity. Addressing these challenges is essential for transforming PDVs from natural plant messengers into engineered, clinically relevant precision therapeutics.

 

This Special Issue aims to integrate advances in basic biology, bioengineering, and translational science to bridge the gap between bench and bedside, thereby accelerating the clinical translation of PDV-based therapeutics.

 

Topics of interest include, but are not limited to:

● Biogenesis, molecular composition, and native biological functions of PDVs;

● Advances and challenges in PDV isolation, purification, characterization, and standardization;

● Mechanisms of PDV–mammalian cell interactions and inter-kingdom communication;

● Therapeutic applications of PDVs in inflammatorydiseases, oncology, metabolic disorders, and regenerative medicine;

● Engineering and functional modification of PDVs for targeted cargo delivery;

● Oral, mucosal, and systemic delivery properties, including stability and biodistribution.

Keywords

Plant-derived vesicles, biogenesis and cargo sorting, inter-kingdom communication, cellular uptake mechanisms, vesicle engineering, precision therapeutics

Submission Deadline

20 May 2026

Submission Information

For Author Instructions, please refer to https://www.oaepublish.com/evcna/author_instructions
For Online Submission, please login at https://www.oaecenter.com/login?JournalId=evcna&IssueId=evcna25111810284
Submission Deadline: 20 May 2026
Contacts: Miranda Ma, Assistant Editor, [email protected]

Published Articles

Coming soon
Extracellular Vesicles and Circulating Nucleic Acids
ISSN 2767-6641 (Online)
Follow Us

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/